These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26777116)

  • 1. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.
    Yin T; Wang G; Ye T; Wang Y
    Sci Rep; 2016 Jan; 6():19534. PubMed ID: 26777116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.
    Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD
    Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
    Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
    Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
    Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
    Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
    Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
    J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKbeta.
    Seo AM; Hong SW; Shin JS; Park IC; Hong NJ; Kim DJ; Lee WK; Lee WJ; Jin DH; Lee MS
    Apoptosis; 2009 Jul; 14(7):913-22. PubMed ID: 19526344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.
    Malvicini M; Fiore E; Ghiaccio V; Piccioni F; Rizzo M; Olmedo Bonadeo L; García M; Rodríguez M; Bayo J; Peixoto E; Atorrasagasti C; Alaniz L; Aquino J; Matar P; Mazzolini G
    Mol Ther; 2015 Sep; 23(9):1444-55. PubMed ID: 26105158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac, a nonsteroidal anti-inflammatory drug, selectively inhibits interferon-gamma-induced expression of the chemokine CXCL9 gene in mouse macrophages.
    Sakaeda Y; Hiroi M; Shimojima T; Iguchi M; Kanegae H; Ohmori Y
    Biochem Biophys Res Commun; 2006 Nov; 350(2):339-44. PubMed ID: 17010317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
    Hossain F; Ucar DA; Monticone G; Ran Y; Majumder S; Larter K; Luu H; Wyczechowska D; Heidari S; Xu K; Shanthalingam S; Matossian M; Xi Y; Burow M; Collins-Burow B; Del Valle L; Hicks C; Zabaleta J; Golde T; Osborne B; Miele L
    Front Immunol; 2023; 14():1244159. PubMed ID: 37901240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.
    Varricchi G; Loffredo S; Marone G; Modestino L; Fallahi P; Ferrari SM; de Paulis A; Antonelli A; Galdiero MR
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane.
    Elwich-Flis S; Sołtysiak-Pawluczuk D; Spławiński J
    Hybrid Hybridomics; 2003 Feb; 22(1):55-60. PubMed ID: 12713691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine (CQ) exerts anti-breast cancer through modulating microenvironment and inducing apoptosis.
    Zhang Y; Cao Y; Sun X; Feng Y; Du Y; Liu F; Yu C; Jin F
    Int Immunopharmacol; 2017 Jan; 42():100-107. PubMed ID: 27912145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
    Jang TJ; Kang HJ; Kim JR; Yang CH
    Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.
    Skopiński P; Bałan BJ; Kocik J; Zdanowski R; Lewicki S; Niemcewicz M; Gawrychowski K; Skopińska-Różewska E; Stankiewicz W
    Mediators Inflamm; 2013; 2013():289789. PubMed ID: 23935247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clever-1/stabilin-1 controls cancer growth and metastasis.
    Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
    Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.
    Yi B; Chang H; Ma R; Feng X; Li W; Piazza GA; Xi Y
    Oncotarget; 2016 Feb; 7(7):7979-92. PubMed ID: 26769851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in drug-resistant tumor.
    Das S; Banerjee K; Roy S; Majumder S; Chatterjee M; Majumdar S; Choudhuri SK
    In Vivo; 2014; 28(5):909-18. PubMed ID: 25189907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.
    Stewart GD; Nanda J; Brown DJ; Riddick AC; Ross JA; Habib FK
    Int J Cancer; 2009 Jan; 124(1):223-32. PubMed ID: 18924134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.